CAAs secrete a variety of inflammatory and cancer-related adipokines such as tumor necrosis factor-α, interleukin-6 (IL-6), and plasminogen activator inhibitor-1 that can increase breast cancer cell proliferation, invasion, metastasis, and therapeutic resistance [20–23]. This evidence concerns the gene IL6 and breast carcinoma.